by Kyle McGuire | May 28, 2017
DENTSPLY SIRONA Our World is Not Flat Mandate It doesn’t matter if you are communicating in the DTC or B2B space. There is no better way to launch a breakthrough product than by featuring the revolutionary thinking that shattered convention. 3H positioned the...
by Kyle McGuire | Mar 10, 2017
VALEANT CANADA Vyloma Mandate The number one issue for all pharmaceutical treatments is enabling compliance. With some diseases unfortunately, there are no “cures”, only “management” therapy options. Genital warts is a disease that falls into this category. Our role...
by Kyle McGuire | Mar 10, 2017
CIPHER PHARMACEUTICALS Actikerall Mandate Ease of use and application is so simple with this product it’s practically cosmetic! Cipher Pharmaceuticals is a growing specialty company with a focus on dermatology. Actikerall™, an Actinic Keratosis (AK) topical...
by Kyle McGuire | Mar 9, 2017
LEO PHARMA Psoriassist Mandate Psoriasis is not contagious, but its unsightly appearance makes it an extremely unsocial disease. Leo Pharma embarked on a groundbreaking journey to create a national psoriasis program and the first-of-its-kind B2B education program for...
by Kyle McGuire | Mar 1, 2017
BAUSCH HEALTH Headlining Brand Drama Not an eye sore any more. Or should we say lip sore? This new topical prescription therapy was also the first combination treatment for cold sores in Canada. 3H launched it to physicians, delivering brand identity and main...
